Medicaid Provider Spending

$1.09 trillion in Medicaid claims data, 2018–2024 · 617K+ providers

A AND R HEALTH SERVICES INC.

NPI: 1639440647 · PITTSBURGH, PA 15233 · Addiction (Substance Use Disorder) Counselor · NPI assigned 01/23/2012

$1.54M
Total Medicaid Paid
35,474
Total Claims
19,384
Beneficiaries
7
Codes Billed
2020-02
First Month
2024-08
Last Month

Provider Details

Authorized OfficialROSCOE, GREGORY (EXECUTIVE DIRECTOR)
NPI Enumeration Date01/23/2012

Related Entities

Other providers sharing the same authorized official: ROSCOE, GREGORY

ProviderCityStateTotal Paid
CURO AEGAR RECOVERY EDUCATION INC WEST CHESTER PA $1.51M
CLEARFIELD JEFFERSON HEAD AND NECK SURGICAL ASSOCIATES, INC. DU BOIS PA $85K

Monthly Spending Trend

Yearly Breakdown

YearClaimsTotal Paid
2020 3,390 $180K
2021 9,455 $383K
2022 10,245 $459K
2023 9,829 $381K
2024 2,555 $138K

Billing Codes

CodeDescriptionClaimsBeneficiariesTotal Paid
G0482 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 15-21 drug class(es), including metabolite(s) if performed 7,907 4,439 $645K
99213 Office or other outpatient visit for the evaluation and management of an established patient, low complexity 14,865 7,629 $630K
80307 Drug test(s), presumptive, any number of drug classes; immunoassay 6,256 3,480 $200K
80305 5,453 3,163 $42K
99212 Office or other outpatient visit for the evaluation and management of an established patient, straightforward 956 636 $21K
G0483 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 22 or more drug class(es), including metabolite(s) if performed 24 24 $2K
99203 Office or other outpatient visit for the evaluation and management of a new patient, low complexity 13 13 $379.75